Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review - Wikidata - awgldk - TriplyDB

Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review

Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review

http://www.wikidata.org/entity/Q26852154

about

Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis Screening for hepatocellular carcinoma: patient selection and perspectives An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis.Hepatocellular carcinoma: early-stage management challenges Cost-Effectiveness of Risk Score-Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis.Racial, social, and clinical determinants of hepatocellular carcinoma surveillance Role of surveillance in prevention of hepatocellular carcinoma.Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis.Accuracy of ultrasound and noninvasive markers of fibrosis to identify patients with cirrhosis Role functioning is associated with survival in patients with hepatocellular carcinoma.Locoregional Therapy for Hepatocellular Carcinoma with and without Extrahepatic Spread Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice.Failure rates in the hepatocellular carcinoma surveillance process.Development and Internal Validation of a Model for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis.Improving the identification of priority populations to increase hepatitis B testing rates, 2012.Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infection.Improving hepatocellular carcinoma screening: applying lessons from colorectal cancer screening.A survey of hepatitis C treatment clinical practice patterns using the newly approved protease inhibitors.Meta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States.Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B.Hepatocellular carcinoma screening practices in the Department of Veterans Affairs: findings from a national facility survey.A primer on effectiveness and efficacy trials The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapy Local geographic variation in chronic liver disease and hepatocellular carcinoma: contributions of socioeconomic deprivation, alcohol retail outlets, and lifestyle.Factors Influencing Surveillance for Hepatocellular Carcinoma in Patients with Liver Cirrhosis.The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis.Hepatocellular carcinoma after kidney transplantation: analysis of Hong Kong Renal Registry.How can we boost colorectal and hepatocellular cancer screening among underserved populations?Quality of Cancer Care in Patients with Cirrhosis and Hepatocellular Carcinoma.Poor adherence to hepatocellular carcinoma surveillance: a systematic review and meta-analysis of a complex issue.Surveillance rates for hepatocellular carcinoma among patients with cirrhosis, chronic hepatitis B, and chronic hepatitis C based on Japanese claims database.The benefit of paracentesis on hospitalized adults with cirrhosis and ascites.Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated?Sofosbuvir-Containing Regimens for Chronic Hepatitis C Are Successful in the Safety-Net Population: A Real-World Experience.Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis.Hospital Volume and Survival After Hepatocellular Carcinoma Diagnosis.Therapeutic delays lead to worse survival among patients with hepatocellular carcinoma.Screening process failures for hepatocellular carcinoma.Diagnostic delays are common among patients with hepatocellular carcinoma.Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.

P2860

Q21144594-0A25CD11-E714-44B1-8C9A-FAFD72E6BE32 Q30355713-3657FE8B-B818-479C-804F-9A9EAE01A979 Q33436257-AD4D10B9-A9CE-47BC-BB4F-44C94896B64F Q33881131-A64BD853-3BD2-4BC9-A3C2-71A291A04693 Q33920344-30EA6360-D51C-4F86-84BF-45D599C5D1DA Q34808945-4AEF3CE7-96F4-486B-9942-88923DB83C15 Q34826014-1521FF0A-5F00-4B4D-97B9-2F503D40E5A7 Q34902635-C09AC7EF-8C87-4D66-B465-59A953390A26 Q35685126-F6425FCD-7A52-4120-B172-50CE660329F1 Q35738710-9FCDD1E3-771F-4CF7-BFAC-5876A0A328A4 Q35951070-276B9BD8-1CA9-4C64-A3BB-9375016EE820 Q36199751-C1135853-3F5F-415E-BE12-0A980D0E9260 Q36213610-9449AAE3-2204-4ECD-9B37-7D4ED3BF7DE4 Q36404471-E90205B5-FE1A-48E3-95D2-97F904E07B2E Q36528950-ECE4651A-BEF5-44BF-A50B-8CAF498A02D7 Q36550695-D4746F37-7E20-47CA-94B7-305F6C1DA8AA Q36724362-8E2E4E11-C269-4743-A553-F5CC4E5D9770 Q37067537-91F38311-A73C-4D2E-B817-D2876F8576F0 Q37184472-9E52AE0E-BD0A-4A7A-9E11-1DFF66A3E4CB Q37226421-B53338BB-7C1A-4DA3-BBD1-2D10011B5C37 Q37380420-0B425BFB-E22C-46D7-874D-AF9933089F1F Q37549837-FDE46DE0-A3FE-43EA-82B0-73580A9C90F9 Q37606028-4A971674-DAEE-4DC1-8C09-1636C45D1A4B Q37624357-DEF3C3C7-CED1-4ADB-9E3D-12C431B8CB80 Q37684567-A3D08A41-DDC4-4C21-B73E-69BAE9FAA8AF Q38180333-7F981420-032C-4F4D-B0AA-D463FA51F3E8 Q38198123-EBC7AFDC-C9EB-4502-AF91-2A2C7687A3A1 Q38511116-5A20947C-3743-4792-B0AB-C7FE1824A22A Q38560093-FCB629C0-8070-4314-BCC9-5BA5D8B7085D Q38611765-3D9C1047-2CD0-46B3-BFA1-ED7B629CBFB1 Q38888501-528D6615-4844-49B9-B0D7-09ABA1A7BB06 Q38934629-B90C3D69-FAD1-4512-AB13-ADE57FD9292F Q39197775-958FAAAB-742C-424D-B1EE-3934E9C12E5D Q39289372-24FAB06C-8A10-4AE5-92B2-4E72BBB250B5 Q39483593-AF91F443-04CD-4B17-9C7D-AFC2418C1DF8 Q39776912-6A992F58-BE9E-4672-8E8E-ECF1FE2D7491 Q40136684-D0E9A010-B9FF-475E-BAB9-17CD315B7123 Q40176654-53D0ED05-37A6-4F03-87CC-1CB910AD06A8 Q40279432-33B3F1C0-82B1-4813-9018-A2093EE137A2 Q40345258-BE12DB3A-86C9-40AE-A8E9-3CF83C879208

P2860

Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review

http://www.wikidata.org/entity/Q26852154

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Utilization of hepatocellular ...... patients: a systematic review

@ast

Utilization of hepatocellular ...... patients: a systematic review

@en

Utilization of hepatocellular ...... patients: a systematic review

@nl

type

label

Utilization of hepatocellular ...... patients: a systematic review

@ast

Utilization of hepatocellular ...... patients: a systematic review

@en

Utilization of hepatocellular ...... patients: a systematic review

@nl

prefLabel

Utilization of hepatocellular ...... patients: a systematic review

@ast

Utilization of hepatocellular ...... patients: a systematic review

@en

Utilization of hepatocellular ...... patients: a systematic review

@nl

P1433

Q26852154-6992442C-B9AE-42F8-AA4F-1712095191D6

P1476

Q26852154-D0870EEE-1D01-4041-82F2-8E43DF4FB3A7

P2093

Q26852154-2D685F56-186A-4270-9639-9FF82D952794

Q26852154-421C1299-1513-4CE1-AFB9-09AD075CE21F

Q26852154-42D43412-F312-4644-8DBB-D888B859D340

Q26852154-674D4CF0-619E-4B9C-9346-1D375CF43332

Q26852154-B9264692-3ED4-4A9B-BAEC-F902D862A540

P2860

Q26852154-0EDAA934-7CA4-40CE-991E-29C26619FDD3

Q26852154-0F15C07C-2057-422F-85C3-40E46553C94D

Q26852154-11C9817B-7EA3-496B-9DAA-1B259E95218D

Q26852154-19A05F43-4D22-45A1-9D61-6013FDF00DF3

Q26852154-23B75DAA-668C-461D-9F00-C73E4CED745E

Q26852154-27670283-0CD4-4AC1-9D7E-64748D366A9F

Q26852154-2CDC5EF1-20DC-4A91-BFBA-F11FB3A8680B

Q26852154-390EE538-7281-4D98-B1AB-B5A5A37552E4

Q26852154-41EA8C07-341D-4A5E-A3A5-3FCD0047B982

Q26852154-486EB53E-10B7-4BB8-855A-66A87A56B773

P2888

Q26852154-0E4374CF-D0D4-4FCC-9DCA-A6827CB77547

P304

Q26852154-A25B5DAE-B7BF-4FDC-A8D1-A573C6033D2B

P31

Q26852154-ADFCDD5E-CFD7-4539-8E13-9BA645947EBD

Q26852154-D280BC08-19E0-45A8-8716-824ECED3C146

P3181

Q26852154-85339E17-D297-4AC0-B797-E0E8DD4F6ECC

P356

Q26852154-8BB90335-B311-42E4-B3A8-F237982BE7E7

P407

Q26852154-689059D5-16A1-4E8D-AA42-303B499851B1

P433

Q26852154-F0A60487-37CA-48F6-BA16-EA565D6D0D51

P478

Q26852154-3DB96F76-F559-4EA8-B79D-BF5EEF0BFF54

P50

Q26852154-2574ED63-22BC-4654-ADF5-936931414050

P577

Q26852154-62056AED-4BE2-4D8D-85DD-6EC1EC17517F

P5875

Q26852154-E9DD1443-B142-4E50-B399-8F62D0E3BAF5

P6179

Q26852154-B9C2FD53-8D22-4206-8D8F-69C238EE6EE2

P698

Q26852154-0887649D-A739-461B-A1F1-781A102EA633

P921

Q26852154-FB847E49-C353-4B11-85E6-1642CCB91F97

P932

Q26852154-580F5B93-874A-4FDF-9124-AC55C340F155

P3181

P356

S11606-011-1952-X

P1433

Journal of General Internal Medicine

P1476

Utilization of hepatocellular ...... patients: a systematic review

@en

P2093

Adam Yopp

http://www.w3.org/2001/XMLSchema#string

Amit G Singal

http://www.w3.org/2001/XMLSchema#string

Celette S Skinner

http://www.w3.org/2001/XMLSchema#string

Milton Packer

http://www.w3.org/2001/XMLSchema#string

William M Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hepatocellular carcinoma: An update

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.

Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

A framework for improving the quality of cancer care: the case of breast and cervical cancer screening.

Some methodologic lessons learned from cancer screening research.

Toward improving the quality of cancer care: addressing the interfaces of primary and oncology-related subspecialty care

Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival.

Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer.

P2888

s11606-011-1952-x

P304

861-867

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

4364891

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S11606-011-1952-X

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51981281

http://www.w3.org/2001/XMLSchema#string

P6179

1034365038

http://www.w3.org/2001/XMLSchema#string

P698

22215266

http://www.w3.org/2001/XMLSchema#string

P921

P932

3378733

http://www.w3.org/2001/XMLSchema#string